My work in physiology was designed to investigate the process of androgen action within target cells and to use this information to provide insight into the clinical disorders of androgen action. The discovery that the circulating male androgen testosterone is 5α-reduced to a more potent hormone, dihydrotestosterone, in target tissues and that dihydrotestosterone and testosterone work by binding to the same androgen receptor protein has provided insight into the inherited syndromes of androgen resistance that impair the formation of the male urogenital tract during embryogenesis and into the role of continued dihydrotestosterone formation in the pathogenesis of prostatic hyperplasia in dogs and men.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Medawar PB. 1979. Advice to a Young Scientist. New York: Harper & Roe [Google Scholar]
  2. Wilson JD, Seldin DW. 1957. Effect of adrenalectomy on production and excretion of ammonia by the kidneys.. Am. J. Physiol. 188:524–28 [Google Scholar]
  3. Albright F, Burnett CH, Smith PH, Parson W. 1942. Pseudo-hypoparathyroidism—an example of ‘Seabright-Bantam Syndrome.’. Endocrinology 30:922–32 [Google Scholar]
  4. Wilson JD, Siperstein MD. 1959. Effect of saturated and unsaturated fats on fecal excretion of end products of cholesterol-4-14 metabolism in the rat.. Am. J. Physiol. 196:596–98 [Google Scholar]
  5. Wilson JD, Siperstein MD. 1959. Effect of saturated and unsaturated fats on hepatic synthesis and biliary excretion of cholesterol by the rat.. Am. J. Physiol. 196:599–602 [Google Scholar]
  6. Wilson JD, Siperstein MD. 1959. Studies on the relationship between glucose oxidation and intermediary metabolism.. III. The influence of pyridine nucleotides on protein synthesis J. Clin. Invest. 38:317–24 [Google Scholar]
  7. Wilson JD, Gibson KD, Udenfriend S. 1960. Studies on the conversion in vitro of serine to ethanolamine by rat liver and brain.. J. Biol. Chem. 235:3539–43 [Google Scholar]
  8. Wilson JD, Gibson KD, Udenfriend S. 1960. Studies on the precursors of the methyl groups of choline in rat liver.. J. Biol. Chem. 235:3213–17 [Google Scholar]
  9. Gibson KD, Wilson JD, Udenfriend S. 1961. The enzymatic conversion of phospholipid ethanolamine to phospholipid choline in rat liver.. J. Biol. Chem. 236:673–79 [Google Scholar]
  10. Stetten DW Jr, Carrigan WT. 1984. NIH: An Account of Research in Its Laboratories and Clinics. Orlando FL: Academic [Google Scholar]
  11. Wilson JD. 1968. The biosynthetic origin of serum cholesterol in the squirrel monkey: evidence for a contribution by the intestinal wall.. J. Clin. Invest. 47:175–87 [Google Scholar]
  12. Dietschy JM, Wilson JD. 1968. Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control.. J. Clin. Invest. 47:166–74 [Google Scholar]
  13. Wilson JD, Lindsey CA Jr. 1965. Studies on the influence of dietary cholesterol on cholesterol metabolism in the isotopic steady state in man.. J. Clin. Invest. 44:1805–14 [Google Scholar]
  14. Wilson JD. 1970. The measurement of the exchangeable pools of cholesterol in the baboon.. J. Clin. Invest. 49:655–65 [Google Scholar]
  15. Dietschy JM, Wilson JD. 1970. The regulation of cholesterol metabolism.. N. Engl. J. Med. 282:1128–38 [Google Scholar]
  16. Kochakian CD. 1959. Mechanisms of androgen action.. Lab. Invest. 8:538–56 [Google Scholar]
  17. Metcalf W, Gross E. 1960. Influence of anabolic steroids on uptake of alpha-aminoisobutyric acid by levator ani muscle.. Science 132:41–42 [Google Scholar]
  18. Wilson JD. 1962. Localization of the biochemical site of testosterone on protein synthesis in the seminal vesicle of the rat.. J. Clin. Invest. 41:153–61 [Google Scholar]
  19. Wilson JD. 1963. The nature of the RNA response to estradiol administration by the uterus of the rat.. Proc. Natl. Acad. Sci. USA 50:93–100 [Google Scholar]
  20. Liao S, Williams-Ashman HG. 1962. An effect of testosterone on amino acid incorporation by prostatic ribonucleoprotein particles.. Proc. Natl. Acad. Sci. USA 48:1956–64 [Google Scholar]
  21. Wilson JD, Loeb PM. 1965. Estrogen and androgen control of cell biosynthesis in target organs. In Developmental and Metabolic Control Mechanisms and Neoplasia 375–91 Baltimore: Williams & Wilkins [Google Scholar]
  22. Chatfield JH Jr, Wilson JD. 1966. Intranuclear localization of testosterone-1,2-H3 in rat prostate.. Clin. Res. 14:61 [Google Scholar]
  23. Bruchovsky N, Wilson JD. 1999. Discovery of the role of dihydrotestosterone in androgen action.. Steroids 64:753–59 [Google Scholar]
  24. Bruchovsky N, Wilson JD. 1968. The conversion of testosterone to 5α-androstan-17β-ol,3-one by rat prostate in vivo and in vitro.. J. Biol. Chem. 143:1314–24 [Google Scholar]
  25. Bruchovsky N, Wilson JD. 1968. The intranuclear binding of testosterone and 5α-androstan-17β-ol,3-one by rat prostate.. J. Biol. Chem. 243:5953–60 [Google Scholar]
  26. Bruchovsky N, Wilson JD. 1968. Evidence that dihydrotestosterone is the active form of testosterone.. Clin. Res. 16:74 [Google Scholar]
  27. Bruchovsky N, Wilson JD. 1968. The mechanism of action of testosterone in rat prostate.. J. Clin. Invest. 47:12 [Google Scholar]
  28. Wilson JD, Bruchovsky N, Chatfield JN. 1969. Intranuclear localization of testosterone in rat prostate.. Excerpta Med. Int. Congr. Ser. 184:17–23 [Google Scholar]
  29. Anderson KM, Liao S. 1968. Selective retention of dihydrotestosterone by prostatic nuclei.. Nature 219:277–79 [Google Scholar]
  30. Dorfman RI, Shipley RA. 1956. Androgens: Biochemistry, Physiology, and Clinical Significance. New York: Wiley & Sons [Google Scholar]
  31. Farnsworth WE, Brown JR, Hughes CA, Cross AA. 1963. Metabolism of testosterone by the human prostate.. JAMA 183:436–39 [Google Scholar]
  32. MacDonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK. 1979. Origin of estrogen in normal men and in women with testicular feminization.. J. Clin. Endocrinol. Metab. 49:905–16 [Google Scholar]
  33. Wilson JD. 1975. Metabolism of testicular androgens. In Handbook of Physiology, Endocrinology, Male Reproductive System, Vol. V, Sec. 7, ed. RO Greep, EB Astwood 491–508 Washington DC: Am. Physiol. Soc [Google Scholar]
  34. Verhoeven G, Wilson JD. 1979. The syndromes of primary hormone resistance.. Metabolism 28:253–89 [Google Scholar]
  35. Jost A. 1953. Problems in fetal endocrinology.. Rec. Prog. Horm. Res. 8:379–418 [Google Scholar]
  36. Wilson JD. 1972. Recent studies on the mechanism of action of testosterone.. N. Engl. J. Med. 287:1284–91 [Google Scholar]
  37. Goldstein JL, Wilson JD. 1974. Hereditary disorders of sexual development in man. In Birth Defects. Int. Congr. Ser. 310, ed AG Motulsky, W Lenz 164–73 New York: Stratton [Google Scholar]
  38. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC. et al. 1974. Familial incomplete male pseudohermaphroditism, type 2.. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias N. Engl. J. Med. 291:944–49 [Google Scholar]
  39. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. 1974. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism.. Science 186:1213–15 [Google Scholar]
  40. Wilson JD. 1975. Dihydrotestosterone formation in cultured human fibroblasts: comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, type 2.. J. Biol. Chem. 250:3498–504 [Google Scholar]
  41. Moore RJ, Griffin JE, Wilson JD. 1975. Diminished 5α-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2.. J. Biol. Chem. 250:7168–72 [Google Scholar]
  42. Moore RJ, Wilson JD. 1976. Steroid 5α-reductase in cultured human fibroblasts: biochemical and genetic evidence for two distinct enzyme activities.. J. Biol. Chem. 251:5895–900 [Google Scholar]
  43. Leshin M, Griffin JE, Wilson JD. 1978. Hereditary male pseudohermaphroditism associated with an unstable form of 5α-reductase.. J. Clin. Invest. 62:685–91 [Google Scholar]
  44. Russell DW, Wilson JD. 1994. Steroid 5α-reductase: two genes/two enzymes.. Annu. Rev. Biochem. 63:25–61 [Google Scholar]
  45. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J. et al. 1992. Molecular genetics of steroid 5α-reductase 2 deficiency.. J. Clin. Invest. 90:799–809 [Google Scholar]
  46. Wilson JD, Griffin JE. 1985. Mutations that impair androgen action.. Trends Genet. 1:335–39 [Google Scholar]
  47. Griffin JE, McPhaul MJ, Russell DW, Wilson JD. 2001. The androgen resistance syndromes: steroid 5α-reductase deficiency, testicular feminization, and related disorders. In The Metabolic and Molecular Basis of Inherited Disease, 8th ed., ed. CR Scriver, AL Beaudet, WS Sly, D Valle 4117–46 New York: McGraw Hill [Google Scholar]
  48. Laue L, Wu S-M, Kudo M, Hsueh AJW, Cutler GB Jr, et al. 1995. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia.. Hum. Mol. Genet. 4:1429–33 [Google Scholar]
  49. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM. et al. 1996. Molecular genetics and pathophysiology of 17β-hydroxysteroid dehydrogenase 3 deficiency.. J. Clin. Endocrinol. Metab. 81:130–36 [Google Scholar]
  50. Wilson JD, Shaw G, Leihy ML, Renfree MB. 2002. The marsupial model for male phenotypic development.. Trends Endocrinol. Metab. 13:78–83 [Google Scholar]
  51. Wilson JD, Leshin M, George FW. 1987. The Sebright bantam chicken and the genetic control of extraglandular aromatase.. Endocr. Rev. 8:363–76 [Google Scholar]
  52. George FW, Wilson JD. 1980. Pathogenesis of the henny feathering trait in the Sebright bantam chicken.. J. Clin. Invest. 66:55–64 [Google Scholar]
  53. George FW, Noble JF, Wilson JD. 1981. Female feathering in Sebright cocks is due to conversion of testosterone to estradiol in skin.. Science 213:557–59 [Google Scholar]
  54. George FW, Wilson JD. 1982. Developmental pattern of increased aromatase activity in the Sebright bantam chicken.. Endocrinology 110:1203–7 [Google Scholar]
  55. Somes RG Jr, George FW, Baron J, Noble JF, Wilson JD. 1984. Inheritance of the henny-feathering trait of the Sebright bantam chicken.. J. Hered. 75:99–102 [Google Scholar]
  56. Leshin M, Baron J, George FW, Wilson JD. 1981. Increased estrogen formation and aromatase activity in fibroblasts cultured from the skin of chickens with the henny feathering trait.. J. Biol. Chem. 256:4341–44 [Google Scholar]
  57. Leshin M, Noble JF, George FW, Wilson JD. 1983. Characterization of the increased estrogen synthesis in skin fibroblasts from the Sebright bantam.. J. Steroid Biochem. 18:33–39 [Google Scholar]
  58. Matsumine H, Wilson JD, McPhaul MJ. 1990. Sebright and Campine chickens express aromatase P-450 mRNA inappropriately in extraglandular tissues and in skin fibroblasts.. Mol. Endocrinol. 4:905–11 [Google Scholar]
  59. Matsumine H, Herbst MA, Ou S-HI, Wilson JD, McPhaul MJ. 1991. Aromatase mRNA in the extragonadal tissues of chickens with the henny-feathering trait is derived from a distinctive promoter structure that contains a segment of a retroviral long terminal repeat.. Functional organization of the Sebright, Leghorn, and Campine aromatase genes J. Biol. Chem. 266:19900–7 [Google Scholar]
  60. Wilson JD. 2001. Fuller Albright and the ‘Seabright-Bantam syndrome.’. Endocrinologist 11S:210–13 [Google Scholar]
  61. Goldstein JL, Brown MS. 1999. Presentation of the Kober medal for 1999 to Jean D. Wilson.. Proc. Assoc. Am. Phys. 111:469–79 [Google Scholar]
  62. Hemsell DL, Edman CD, Marks JF, Siiteri PK, MacDonald PC. 1977. Massive aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.. J. Clin. Invest. 60:455–64 [Google Scholar]
  63. Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D. et al. 1998. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription.. J. Clin. Endocrinol. Metab. 83:1348–57 [Google Scholar]
  64. Wilson JD. 1980. The pathogenesis of benign prostatic hyperplasia.. Am. J. Med. 68:745–56 [Google Scholar]
  65. Gloyna RE, Wilson JD. 1969. A comparative study of the conversion of testosterone to 17β-hydroxy-5α-androstan-3-one by prostate and epididymis.. J Clin. Endocrinol. Metab. 29:970–77 [Google Scholar]
  66. Wilson JD, Gloyna RE. 1970. The intranuclear metabolism of testosterone in the accessory organs of reproduction.. Rec. Prog. Horm. Res. 26:309–36 [Google Scholar]
  67. Siiteri PK, Wilson JD. 1970. Dihydrotestosterone in prostatic hypertrophy.. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man J. Clin. Invest. 49:1737–45 [Google Scholar]
  68. Gloyna RE, Siiteri PK, Wilson JD. 1970. Dihydrotestosterone in prostatic hypertrophy II.. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostatic growth in the dog J. Clin. Invest. 49:1746–53 [Google Scholar]
  69. Wilson JD, Gloyna RE, Siiteri PK. 1975. Androgen metabolism in the hypertrophic prostate.. J. Steroid Biochem. 6:443–45 [Google Scholar]
  70. Walsh PC, Wilson JD. 1976. The induction of prostatic hypertrophy in the dog with androstanediol.. J. Clin. Invest. 57:1093–97 [Google Scholar]
  71. Bruchovsky N. 1971. Comparison of the metabolites formed in rat prostate following in vivo administration of seven natural androgens.. Endocrinology 89:1212–16 [Google Scholar]
  72. Moore RJ, Gazak JM, Quebbeman JF, Wilson JD. 1979. Concentration of dihydrotestosterone and 3α-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.. J. Clin. Invest. 64:1003–10 [Google Scholar]
  73. Wenderoth UK, George FW, Wilson JD. 1983. The effect of a 5α-reductase inhibitor on androgen-mediated growth of the dog prostate.. Endocrinology 113:569–73 [Google Scholar]
  74. Moore RJ, Gazak JM, Wilson JD. 1979. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17β-estradiol.. J. Clin. Invest. 63:351–57 [Google Scholar]
  75. Zuckerman S, Groome JR. 1937. The aetiology of benign enlargement of the prostate in the dog.. J. Pathol. Bacteriol. 44:113–24 [Google Scholar]
  76. Rittmaster RS. 1994. Finasteride.. N. Engl. J. Med. 330:120–25 [Google Scholar]
  77. McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E. 1992. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with prostatic hyperplasia.. J. Clin. Endocrinol. Metab. 74:505–8 [Google Scholar]
  78. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M. et al. 1998. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.. N. Engl. J. Med. 338:557–63 [Google Scholar]
  79. McConnell JD. 2002. The long term effects of medical therapy on the progression of BPH: results from the MTOPS trial.. J. Urol. 167:265S [Google Scholar]
  80. Wilson JD. 2001. The role of 5α-reduction in steroid hormone physiology.. Reprod. Fertil. Dev. 13:673–78 [Google Scholar]
  81. Goldstein JL, Wilson JD. 1972. Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization.. J. Clin. Invest. 51:1647–58 [Google Scholar]
  82. Grino PB, Griffin JE, Wilson JD. 1990. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone.. Endocrinology 126:1165–72 [Google Scholar]
  83. Desylpere J-P, Young M, Wilson JD, McPhaul MJ. 1992. Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene.. Mol. Cell Endocrinol. 88:15–22 [Google Scholar]
  84. George FW, Russell DW, Wilson JD. 1991. Feed-forward control of prostatic growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase.. Proc. Natl. Acad. Sci. USA 88:8044–47 [Google Scholar]
  85. Mahendroo MS, Cala KM, Hess DL, Russell DW. 2001. Unexpected virilization in male mice lacking steroid 5α-reductase enzymes.. Endocrinology 142:4652–62 [Google Scholar]
  86. Grino PB, Isidro-Gutierrez RF, Griffin JE, Wilson JD. 1989. Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsible to high dose androgen therapy.. J Clin. Endocrinol. Metab. 68:578–84 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error